fluoxetine and nicotine

fluoxetine has been researched along with nicotine in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19903 (7.32)18.7374
1990's3 (7.32)18.2507
2000's22 (53.66)29.6817
2010's12 (29.27)24.3611
2020's1 (2.44)2.80

Authors

AuthorsStudies
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM1
Topliss, JG; Yoshida, F1
Keserü, GM1
Caron, G; Ermondi, G1
Nagashima, R; Nishikawa, T; Tobita, M1
Dansette, PM; Fontana, E; Poli, SM1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Abraham, MH; Acree, WE; Ibrahim, A1
Jia, L; Sun, H1
Ahman, M; Holmén, AG; Wan, H1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Crooks, PA; Deaciuc, AG; Dwoskin, LP; Grinevich, VP; Hojahmat, M; Horton, DB; Miller, DK; Norrholm, SD1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Allen, JM; Fairweather, I; Halton, DW; McKay, DM1
Davidson, RK; Dilsauer, SC; Hariharen, M1
Davidson, RK; Dilsaver, SC1
Callaway, CW; Geyer, MA; Rempel, NL1
Bjornsdottir, US; Blondal, T; Gudmundsson, LJ; Hilmarsdottir, H; Jonsdottir, D; Kristjansson, F; Nilsson, F; Tomasson, K1
Branchek, TA; Calligaro, DO; Czachura, JF; Dreshfield-Ahmad, LJ; Evans, DC; Hemrick-Luecke, SK; Kallman, MJ; Kendrick, WT; Leander, JD; Nelson, DL; Overshiner, CD; Rasmussen, K; Wainscott, DB; Wolff, MC; Wong, DT; Xu, YC; Zgombick, JM1
Downey, KK; Schuh, KJ; Schuh, LM; Stamat, HM1
Harrison, AA; Liem, YT; Markou, A1
Breitinger, HG; Geetha, N; Hess, GP1
Jeong, MS; Kim, CJ; Kim, KW; Park, EY; Park, JW; Shin, BS; Shin, MS; Woo, RS; Zhao, RJ1
Hurt, RD1
Leslie, FM; O'Leary, KT1
Caboche, J; Girault, JA; Hervé, D; Pagès, C; Valjent, E1
Bonilla-Jaime, H; Vázquez-Palacios, G; Velázquez-Moctezuma, J2
Harvey, I; Lilford, R; Song, F1
Alcantara, LF; Bolaños-Guzmán, CA; Iñiguez, SD; Maffeo, ML; Manojlovic, Z; Parise, EM; Schuh, B; Warren, BL1
Bifone, A; Gozzi, A; Schwarz, AJ1
Bonilla-Jaime, H; Guevara Pérez, MA; Hernández-González, M; Vázquez-Palacios, G1
Burgoon, LD; Johnstone, AF; Lin, BJ; Mack, CM; Shafer, TJ; Turner, JD1
Alcantara, LF; Bolaños-Guzmán, CA; Iñiguez, SD; Parise, EM; Warren, BL1
Satoh, N; Takahashi, K; Toyohira, Y; Yanagihara, N1
Bernabeu, RO; Faillace, MP; Zwiller, J1
Connor, DA; Gould, TJ1
Braida, D; Dellarole, I; Morara, S; Ponzoni, L; Sala, M1

Reviews

4 review(s) available for fluoxetine and nicotine

ArticleYear
The role of receptor binding in drug discovery.
    Journal of natural products, 1993, Volume: 56, Issue:4

    Topics: Animals; Drug Design; Humans; Receptors, Drug

1993
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
    Current drug metabolism, 2005, Volume: 6, Issue:5

    Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic

2005
Pharmacotherapy for alcoholic smokers.
    Alcoholism, clinical and experimental research, 2002, Volume: 26, Issue:12

    Topics: Alcoholism; Animals; Fluoxetine; Humans; Nicotine; Smoking

2002
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.
    Journal of clinical epidemiology, 2008, Volume: 61, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome

2008

Trials

2 trial(s) available for fluoxetine and nicotine

ArticleYear
The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.
    Addiction (Abingdon, England), 1999, Volume: 94, Issue:7

    Topics: Adult; Aged; Algorithms; Antidepressive Agents, Second-Generation; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Respiratory Therapy; Smoking Cessation

1999
Subjective and discriminative stimulus effects of two de-nicotinized cigarettes with different tar yields.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2001, Volume: 3, Issue:1

    Topics: Adult; Blood Pressure; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Nicotine; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder

2001

Other Studies

35 other study(ies) available for fluoxetine and nicotine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship

2003
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
    Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9

    Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water

2005
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
    Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11

    Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization

2008
Support vector machines classification of hERG liabilities based on atom types.
    Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve

2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.
    Bioorganic & medicinal chemistry, 2010, Jan-15, Volume: 18, Issue:2

    Topics: Animals; Esters; Ligands; Lobeline; Male; Molecular Structure; Neurons; Neurotransmitter Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
The effects of cholinergic and serotoninergic drugs on motility in vitro of Haplometra cylindracea (Trematoda: Digenea).
    Parasitology, 1989, Volume: 99 Pt 2

    Topics: Acetylcholine; Animals; Atropine; Carbachol; Fluoxetine; Methysergide; Movement; Nicotine; Parasympathomimetics; Physostigmine; Rana temporaria; Reserpine; Serotonin; Serotonin Antagonists; Trematoda; Tubocurarine

1989
Desipramine subsensitizes nicotinic mechanism involved in regulating core temperature.
    Psychiatry research, 1988, Volume: 25, Issue:1

    Topics: Amitriptyline; Animals; Body Temperature Regulation; Brain; Desipramine; Fluoxetine; Light; Lithium; Male; Nicotine; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Nicotinic

1988
Fluoxetine subsensitizes a nicotinic mechanism involved in the regulation of core temperature.
    Life sciences, 1987, Aug-31, Volume: 41, Issue:9

    Topics: Animals; Antidepressive Agents; Body Temperature Regulation; Fluoxetine; Nicotine; Propylamines; Rats

1987
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 8, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Caffeine; Designer Drugs; Dopamine Agents; Dose-Response Relationship, Drug; Fluoxetine; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synapses

1993
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Body Temperature; Columbidae; Corticosterone; Depression; Discrimination Learning; Drug Interactions; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lip; Male; Microdialysis; Neurons; Nicotine; Piperidines; Posture; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Sulfur Radioisotopes

2000
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 25, Issue:1

    Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; Disease Models, Animal; Drug Combinations; Electric Stimulation; Fluoxetine; Male; Mecamylamine; Neurons; Nicotine; Nicotinic Antagonists; Piperazines; Rats; Rats, Wistar; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder

2001
Inhibition of the serotonin 5-HT3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques.
    Biochemistry, 2001, Jul-27, Volume: 40, Issue:28

    Topics: Animals; Binding Sites; Cocaine; Dose-Response Relationship, Drug; Drug Synergism; Electrophysiology; Fluoxetine; Kinetics; Mice; Nicotine; Patch-Clamp Techniques; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Tumor Cells, Cultured

2001
Mechanism of nicotine-evoked release of 3H-noradrenaline in human cerebral cortex slices.
    British journal of pharmacology, 2002, Volume: 137, Issue:7

    Topics: Adolescent; Adult; Arginine; Calcium; Calcium Channel Blockers; Cerebral Cortex; Dihydro-beta-Erythroidine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Ganglionic Stimulants; Guanylate Cyclase; Humans; In Vitro Techniques; Indazoles; Male; Mecamylamine; Methylene Blue; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nicotine; Nicotinic Antagonists; Nitrendipine; Nitric Oxide Synthase; Norepinephrine; omega-Conotoxin GVIA; Oxadiazoles; Purinones; Quinoxalines; Tetrodotoxin; Tritium; Tubocurarine

2002
Developmental regulation of nicotinic acetylcholine receptor-mediated [3H]norepinephrine release from rat cerebellum.
    Journal of neurochemistry, 2003, Volume: 84, Issue:5

    Topics: Age Factors; Aging; Animals; Animals, Newborn; Cerebellum; Dose-Response Relationship, Drug; Female; Fluoxetine; Gene Expression Regulation, Developmental; In Vitro Techniques; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Symporters; Tritium

2003
Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.
    The European journal of neuroscience, 2004, Volume: 19, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzazepines; Brain; Caffeine; Central Nervous System Stimulants; Cocaine; Desipramine; Dopamine Antagonists; Dronabinol; Enzyme Activation; Fluoxetine; Immunohistochemistry; Male; Mice; Mitogen-Activated Protein Kinases; Morphine; Muscarinic Antagonists; Neurons; Nicotine; Nicotinic Agonists; Scopolamine; Selective Serotonin Reuptake Inhibitors

2004
Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine [correction of flouxetine].
    Pharmacology, biochemistry, and behavior, 2004, Volume: 78, Issue:1

    Topics: Animals; Antidepressive Agents; Depression; Drug Administration Schedule; Drug Interactions; Drug Synergism; Fluoxetine; Immobilization; Male; Motor Activity; Nicotine; Rats; Rats, Wistar; Swimming

2004
Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine.
    Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1

    Topics: Animals; Animals, Newborn; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Fluoxetine; Injections, Subcutaneous; Motor Activity; Nicotine; Nicotinic Agonists; Pregnancy; Rats; Rats, Wistar; Serotonin; Swimming

2005
Nicotine exposure during adolescence induces a depression-like state in adulthood.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:6

    Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Cholinergic Agents; Depression; Emotions; Fluoxetine; Food Preferences; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Reward; Stress, Psychological; Weight Gain

2009
Community structure in networks of functional connectivity: resolving functional organization in the rat brain with pharmacological MRI.
    NeuroImage, 2009, Aug-01, Volume: 47, Issue:1

    Topics: Algorithms; Animals; Brain; Brain Mapping; Dextroamphetamine; Dopamine Uptake Inhibitors; Fluoxetine; Magnetic Resonance Imaging; Male; Neural Pathways; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors

2009
Nicotine and fluoxetine induce arousing effects on sleep-wake cycle in antidepressive doses: a possible mechanism of antidepressant-like effects of nicotine.
    Pharmacology, biochemistry, and behavior, 2010, Volume: 94, Issue:4

    Topics: Animals; Antidepressive Agents; Circadian Rhythm; Drug Interactions; Fluoxetine; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Sleep Stages; Time Factors; Wakefulness

2010
Burst and principal components analyses of MEA data for 16 chemicals describe at least three effects classes.
    Neurotoxicology, 2014, Volume: 40

    Topics: Acetaminophen; Action Potentials; Animals; Cells, Cultured; Cerebral Cortex; Data Interpretation, Statistical; Fluoxetine; GABA Antagonists; Kainic Acid; Microelectrodes; Muscimol; Nerve Net; Neurons; Nicotine; Pesticides; Principal Component Analysis; Rats; Rats, Long-Evans; Verapamil

2014
Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.
    Psychopharmacology, 2014, Volume: 231, Issue:8

    Topics: Animals; Cocaine; Conditioning, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Fluoxetine; Gene Expression; Male; MAP Kinase Signaling System; Methylphenidate; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Psychotropic Drugs; RNA, Messenger; Second Messenger Systems; Space Perception; Time Factors; Ventral Tegmental Area

2014
Effects of various pharmacological agents on the function of norepinephrine transporter.
    Journal of UOEH, 2015, Mar-01, Volume: 37, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenergic Neurons; Animals; Cells, Cultured; Fluoxetine; Genistein; Humans; Ketamine; Nerve Endings; Nicotine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pentazocine; Sympathetic Nervous System; Synaptic Transmission

2015
Effects of combined nicotine and fluoxetine treatment on adult hippocampal neurogenesis and conditioned place preference.
    Neuroscience, 2015, Aug-06, Volume: 300

    Topics: Animals; Conditioning, Psychological; Dentate Gyrus; Drug Interactions; Fluoxetine; Histone Deacetylase 2; Male; Nerve Tissue Proteins; Neurogenesis; Neurons; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats, Sprague-Dawley; Receptors, Growth Factor; Receptors, Nerve Growth Factor; Reward; Selective Serotonin Reuptake Inhibitors; Spatial Behavior

2015
Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.
    Neuropharmacology, 2017, Volume: 125

    Topics: Aging; Animals; Anxiety; Brain-Derived Neurotrophic Factor; Conditioning, Psychological; Fear; Fluoxetine; Hippocampus; Learning Disabilities; Male; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nootropic Agents; Prefrontal Cortex; Substance-Related Disorders

2017
Fluoxetine rescues the depressive-like behaviour induced by reserpine and the altered emotional behaviour induced by nicotine withdrawal in zebrafish: Involvement of tyrosine hydroxylase.
    Journal of psychopharmacology (Oxford, England), 2023, Volume: 37, Issue:11

    Topics: Anhedonia; Animals; Calcitonin Gene-Related Peptide; Fluoxetine; Nicotine; Reserpine; Substance Withdrawal Syndrome; Tyrosine 3-Monooxygenase; Zebrafish

2023